MTOR and colorectal carcinoma: Aspirin enhances the sensitivity of CRC cells with oncogenic PIK3CA activation to ferroptosis induction by inhibiting the AKT/mTOR pathway, suppressing SREBP-1 expression, and reducing SCD1-mediated lipogenesis [105].